Interleukin-1 alpha, human recombinant

DB14076InvestigationalProtein Based Therapies

Interleukin-1 alpha, human recombinant: Overview.

Mechanism: Pharmacologically active on Interleukin-1 alpha
Curator reviewed
Also known as: Dermapoietin · Dermatopoietin · Hematopoietin-1 · IL-1 alpha · IL-1α

Resolves to

Compound

Clinical / RWD

Targets

What you can answer from here — as of July 13, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1Marketed productAcross 1 country and 1 labeller

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Interleukin-1 alpha, human recombinant, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.